DARCEY STOCKLAND: Open Payments
NPI 1174745467 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 19 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $341 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $110 |
| Inspire Medical Systems, Inc. | 2 | $86 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: INSPIRE, LEQVIO, QULIPTA, UBRELVY, ELIQUIS, TZIELD, LILETTA, CAPLYTA.
Industry payments across SD — which companies pay providers there.
